Transforming growth factor β1 gene variants increase transcription and are associated with liver cirrhosis in Chinese

Cytokine

Volumn 43, Issue 1, 2008, Pages 20-25

  Wang, Hao ^b   Zhao, Yun Peng ^a   Gao, Chun Fang ^a   Ji, Qiang ^a   Gressner, Axel M ^c   Yang, Zai Xing ^b   Weiskirchen, Ralf ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cirrhosis; Genotype; Polymorphism; Promoter; Transforming growth factor 1 (TGF 1)

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

ADULT; AGED; ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; FEMALE; GENE FREQUENCY; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MICE; MIDDLE AGED; NIH 3T3 CELLS; POINT MUTATION; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; VARIATION (GENETICS);

HEPATITIS B VIRUS;

EID: 45449116102     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.04.013     Document Type: Article

References (27)

1. Bataller R., North K.E., and Brenner D.A. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37 (2003) 493-503
2. Seeff L.B. Natural history of chronic hepatitis C. Hepatology 36 (2002) S35-S46
3. Marcellin P., Asselah T., and Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 36 (2002) S47-S56
4. Sheldon J., Rodes B., Zoulim F., Bartholomeusz A., and Soriano V. Mutations affecting the replication capacity of the hepatitis B virus. J Viral Hepatol 13 (2006) 427-434
5. Yang S.Q., Wang Z.H., Yang L., Hu J.G., Yang W.G., and Hou J.L. Distribution of hepatitis B virus genotypes in Ningxia Hui nationality and its clinical significance. Zhonghua Gan Zang Bing Za Zhi 14 (2006) 466-467
6. Gressner A.M., Weiskirchen R., Breitkopf K., and Dooley S. Roles of TGF-β in hepatic fibrosis. Front Biosci 7 (2002) d793-d807
7. Ueberham E., Low R., Ueberham U., Schonig K., Bujard H., and Gebhardt R. Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37 (2003) 1067-1078
8. Ueno H., Sakamoto T., Nakamura T., Qi Z., Astuchi N., Takeshita A., et al. A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther 11 (2000) 33-42
9. Arias M., Sauer-Lehnen S., Treptau J., Janoschek N., Theuerkauf I., Buettner R., et al. Expression of a transforming growth factor-β1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol 3 (2003) 29
10. Dooley S., Hamzavi J., Breitkopf K., Wiercinska E., Said H.M., Lorenzen J., et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125 (2003) 178-191
11. Yata Y., Gotwals P., Koteliansky V., and Rockey D.C. Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-β soluble receptor: implications for antifibrotic therapy. Hepatology 35 (2002) 1022-1030
12. Gao C.F., Xu L.L., Wang H., Zhao W.J., and Kong X.T. Pilot study of TGFβ1 detection for the diagnosis of liver fibrosis in chronic hepatic diseases. Chin Hepatol 7 (2002) 28-29
13. Gewaltig J., Mangasser-Stephan K., Gartung C., Biesterfeld S., and Gressner A.M. Association of polymorphisms of the transforming growth factor-β1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 316 (2002) 83-94
14. Park B.L., Han I.K., Lee H.S., Kim L.H., Kim S.J., and Shin H.D. Identification of novel variants in transforming growth factor-beta 1 (TGFB1) gene and association analysis with bone mineral density. Hum Mutat 22 (2003) 257-258
15. Watanabe Y., Kinoshita A., Yamada T., Ohta T., Kishino T., Matsumoto N., et al. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-β1 (TGF-β1) and its signaling pathway. J Hum Genet 47 (2002) 478-483
16. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., et al. Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 8 (1999) 93-97
17. Tag C.G., Mengsteab S., Hellerbrand C., Lammert F., Gressner A.M., and Weiskirchen R. Analysis of the transforming growth factor-β1 (TGF-β1) codon 25 gene polymorphism by LightCycler-analysis in patients with hepatitis C infection. Cytokine 24 (2003) 173-181
18. Hao W., Mengsteab S., Tag C.G., Chun Fang G., Hellerbrand C., Lammert F., et al. Transforming growth factor-β1 gene polymorphisms are associated with severity of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol 11 (2005) 1929-1936
19. Infante-Rivard C., Esnaola S., and Villencuve J.P. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhosis. Hepatology 7 (1987) 660-664
20. Chinese Society of Infectious Diseases and Parasitology, and Chinese Society of Hepatology of Chinese Medical Association. The programme of prevention and cure for viral hepatitis. Zhonghua Ganzangbing Zazhi 8 (2000) 324-329
21. Merican I., Guan R., Amarapuka D., Alexander M.J., Chutaputti A., Chien R.N., et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 5 (2000) 1356-1361
22. Chen C.J., Yang H.I., Su J., Jen C.L., You S.L., Lu S.N., et al., REVEAL-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006) 65-73
23. Ding X., Mizokami M., Yao G., Xu B., Orito E., Ueda R., and Nakanishi M. Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China. Intervirology 44 (2001) 43-47
24. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B. Zhonghua Ganzangbing Zazhi, 2005;13:881-91.
25. Lee J.G., Ahn C., Yoon S.C., Park J.H., Eo H.S., No J.J., et al. No association of the TGF-β1 gene polymorphisms with the renal progression in autosomal dominant polycystic kidney disease (ADPKD) patients. Clin Nephrol 59 (2003) 10-16
26. Ohtsuka T., Yamakage A., and Yamazaki S. The polymorphism of transforming growth factor-β1 gene in Japanese patients with systemic sclerosis. Br J Dermatol 147 (2002) 458-463
27. Bao G.Y., Gao C.F., Zhong R.Q., and Kong X.T. Construction and activity analysis of recombinant plasmids of transforming growth factor β1 promoter gene. Acad J Sec Mil Med Univ 25 (2004) 638-664